Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Genomics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Genomics market research.
Key companies engaged in the Genomics industry include 10X Genomics Inc., Abcam Plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Genomics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Genomics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Genomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
By Region
The Genomics report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nucleic Acids Extraction and QC
1.2.3 Gene Expression Services
1.2.4 Genotyping Services and Pharmacogenomics
1.2.5 Data Analysis and Interpretation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Genomics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical
1.3.4 Research Institutes
1.3.5 Agrochemical
1.3.6 Chemical
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics Market Perspective (2018-2029)
2.2 Genomics Growth Trends by Region
2.2.1 Global Genomics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genomics Historic Market Size by Region (2018-2023)
2.2.3 Genomics Forecasted Market Size by Region (2024-2029)
2.3 Genomics Market Dynamics
2.3.1 Genomics Industry Trends
2.3.2 Genomics Market Drivers
2.3.3 Genomics Market Challenges
2.3.4 Genomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics Players by Revenue
3.1.1 Global Top Genomics Players by Revenue (2018-2023)
3.1.2 Global Genomics Revenue Market Share by Players (2018-2023)
3.2 Global Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomics Revenue
3.4 Global Genomics Market Concentration Ratio
3.4.1 Global Genomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics Revenue in 2022
3.5 Genomics Key Players Head office and Area Served
3.6 Key Players Genomics Product Solution and Service
3.7 Date of Enter into Genomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics Breakdown Data by Type
4.1 Global Genomics Historic Market Size by Type (2018-2023)
4.2 Global Genomics Forecasted Market Size by Type (2024-2029)
5 Genomics Breakdown Data by Application
5.1 Global Genomics Historic Market Size by Application (2018-2023)
5.2 Global Genomics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genomics Market Size (2018-2029)
6.2 North America Genomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genomics Market Size by Country (2018-2023)
6.4 North America Genomics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomics Market Size (2018-2029)
7.2 Europe Genomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genomics Market Size by Country (2018-2023)
7.4 Europe Genomics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomics Market Size (2018-2029)
8.2 Asia-Pacific Genomics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genomics Market Size by Region (2018-2023)
8.4 Asia-Pacific Genomics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomics Market Size (2018-2029)
9.2 Latin America Genomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genomics Market Size by Country (2018-2023)
9.4 Latin America Genomics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics Market Size (2018-2029)
10.2 Middle East & Africa Genomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genomics Market Size by Country (2018-2023)
10.4 Middle East & Africa Genomics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10X Genomics Inc.
11.1.1 10X Genomics Inc. Company Detail
11.1.2 10X Genomics Inc. Business Overview
11.1.3 10X Genomics Inc. Genomics Introduction
11.1.4 10X Genomics Inc. Revenue in Genomics Business (2018-2023)
11.1.5 10X Genomics Inc. Recent Development
11.2 Abcam Plc
11.2.1 Abcam Plc Company Detail
11.2.2 Abcam Plc Business Overview
11.2.3 Abcam Plc Genomics Introduction
11.2.4 Abcam Plc Revenue in Genomics Business (2018-2023)
11.2.5 Abcam Plc Recent Development
11.3 Agilent Technologies Inc.
11.3.1 Agilent Technologies Inc. Company Detail
11.3.2 Agilent Technologies Inc. Business Overview
11.3.3 Agilent Technologies Inc. Genomics Introduction
11.3.4 Agilent Technologies Inc. Revenue in Genomics Business (2018-2023)
11.3.5 Agilent Technologies Inc. Recent Development
11.4 Becton Dickinson and Co.
11.4.1 Becton Dickinson and Co. Company Detail
11.4.2 Becton Dickinson and Co. Business Overview
11.4.3 Becton Dickinson and Co. Genomics Introduction
11.4.4 Becton Dickinson and Co. Revenue in Genomics Business (2018-2023)
11.4.5 Becton Dickinson and Co. Recent Development
11.5 BGI Genomics Co. Ltd.
11.5.1 BGI Genomics Co. Ltd. Company Detail
11.5.2 BGI Genomics Co. Ltd. Business Overview
11.5.3 BGI Genomics Co. Ltd. Genomics Introduction
11.5.4 BGI Genomics Co. Ltd. Revenue in Genomics Business (2018-2023)
11.5.5 BGI Genomics Co. Ltd. Recent Development
11.6 Bio Rad Laboratories Inc.
11.6.1 Bio Rad Laboratories Inc. Company Detail
11.6.2 Bio Rad Laboratories Inc. Business Overview
11.6.3 Bio Rad Laboratories Inc. Genomics Introduction
11.6.4 Bio Rad Laboratories Inc. Revenue in Genomics Business (2018-2023)
11.6.5 Bio Rad Laboratories Inc. Recent Development
11.7 Danaher Corp.
11.7.1 Danaher Corp. Company Detail
11.7.2 Danaher Corp. Business Overview
11.7.3 Danaher Corp. Genomics Introduction
11.7.4 Danaher Corp. Revenue in Genomics Business (2018-2023)
11.7.5 Danaher Corp. Recent Development
11.8 Eppendorf AG
11.8.1 Eppendorf AG Company Detail
11.8.2 Eppendorf AG Business Overview
11.8.3 Eppendorf AG Genomics Introduction
11.8.4 Eppendorf AG Revenue in Genomics Business (2018-2023)
11.8.5 Eppendorf AG Recent Development
11.9 Eurofins Scientific SE
11.9.1 Eurofins Scientific SE Company Detail
11.9.2 Eurofins Scientific SE Business Overview
11.9.3 Eurofins Scientific SE Genomics Introduction
11.9.4 Eurofins Scientific SE Revenue in Genomics Business (2018-2023)
11.9.5 Eurofins Scientific SE Recent Development
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Detail
11.10.2 F. Hoffmann-La Roche Ltd. Business Overview
11.10.3 F. Hoffmann-La Roche Ltd. Genomics Introduction
11.10.4 F. Hoffmann-La Roche Ltd. Revenue in Genomics Business (2018-2023)
11.10.5 F. Hoffmann-La Roche Ltd. Recent Development
11.11 IQVIA
11.11.1 IQVIA Company Detail
11.11.2 IQVIA Business Overview
11.11.3 IQVIA Genomics Introduction
11.11.4 IQVIA Revenue in Genomics Business (2018-2023)
11.11.5 IQVIA Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Detail
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Genomics Introduction
11.12.4 Beckman Coulter Revenue in Genomics Business (2018-2023)
11.12.5 Beckman Coulter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
Published By : QY Research